GEN Exclusives

More »

GEN News Highlights

More »
Dec 19, 2007

Cancer Therapeutics and an Australian Medical Institute Join Forces to Develop Anticancer Drugs against Unique Target

  • Cancer Therapeutics CRC and the Queensland Institute of Medical Research (QIMR) agreed to work together to discover and develop new treatments for cancer. The R&D work will focus on a particular protein target that is reportedly critical to the genetic repair processes that promote cancer cell survival and keep them replicating.

    Kum Kum Khanna, Ph.D., and Derek Richard in the Cancer and Cell Biology Division at QIMR identified this molecule. The biology of the protein appears to make it an extremely valuable target for therapeutic intervention, according to Dr. Khanna.

    By discovering small molecules that inhibit the protein, Cancer Therapeutics CRC hopes to develop drugs that may stop cancers from growing and promote cancer cell death.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

The Triple Package and Success

One theory for explaining “success," put forward by Amy Chua Jed Rubenfeld, posits cultural traits such as a superiority complex, personal insecurity and impulse control. Union College professors Joshua Hart and Christopher Chabris counter that intelligence, conscientiousness, and economic advantage are the most likely elements of success, regardless of ethnicity. Do you think that Hart-Chabris make a better argument for achieving success than the Chua-Rubenfeld theory?

More »